Global Oligonucleotide Synthesis Market 2019-2023 | 10% CAGR Projection Over the Next Five Years | Technavio

Technavio has announced its latest market research report titled global oligonucleotide synthesis market 2019-2023. (Graphic: Business Wire)

LONDON--()--The global oligonucleotide synthesis market is expected to post a CAGR over 10% during the period 2019-2023, according to the latest market research report by Technavio. Request a free sample report

The increasing research activities in the pharmaceutical and biotechnology sectors is expected to boost the growth of the oligonucleotide synthesis market during the forecast period. The increasing prevalence of chronic and life-threatening diseases have prompted pharmaceutical companies and research firms to focus on R&D activities for the development of effective therapeutics. As a result, advances in life sciences research is leading to an improved understanding of biological systems. The development of oligonucleotide synthesis technologies has helped pharmaceutical and biotechnology researchers with molecular-level development, design, and modification of biological systems.

To learn more about the global trends impacting the future of market research, download free sample: https://www.technavio.com/talk-to-us?report=IRTNTR32105

As per Technavio, the increasing focus on R&D of new oligonucleotide therapies will have a positive impact on the market and contribute to its growth significantly over the forecast period. This research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global Oligonucleotide Synthesis Market: Increasing Focus on R&D of New Oligonucleotide Therapies

Although oligonucleotide therapeutics has been in the development for the last three decades, only a limited number of drugs have been approved till date. However, pharmaceutical and biotechnology companies are increasingly focusing on the R&D of new oligonucleotide drugs due to their potential to treat many diseases that are untreatable by conventional therapies. Moreover, continuous advances in science and technology have helped overcome the challenges related to the administration, cellular uptake, biodistribution, and adverse side effects of oligonucleotide therapeutics. Thus, the increasing focus on R&D of new oligonucleotide therapies will drive oligonucleotide synthesis market growth during the forecast period.

“Apart from the increasing focus on R&D of new oligonucleotide therapies, other factors such as the strategic collaborations and partnerships, and the rise in demand for low-cost and high-throughput oligonucleotide synthesis will have a significant impact on the growth of the oligonucleotide synthesis market during the forecast period,says a senior analyst at Technavio.

Register for a free trial today and gain instant access to 10,000+ market research reports.

Technavio's SUBSCRIPTION platform

Global Oligonucleotide Synthesis Market: Segmentation Analysis

This market research report segments the global oligonucleotide synthesis market by end-user (pharmaceutical and biotechnology companies, research and academic institutes, diagnostic laboratories, and hospitals) and by region (North America, Europe, Asia, and ROW).

The North American region led the market in 2018, followed by Europe, Asia, and ROW respectively. The growth of the oligonucleotide synthesis market share in North America is attributed to factors such as the growing approval of novel therapies and the commercial availability of these treatments in the region.

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.

Request a free sample report

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

The global oligonucleotide synthesis market is expected to post a CAGR over 10% during the period 2019-2023, according to Technavio.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com